Comments on: CD19-CD22 CAR-T cells by Shanghai Biomed-Union Biotechnology for Unspecified B-Cell Lymphomas: Likelihood of Approval /data-insights/cd19-cd22-car-t-cells-shanghai-biomed-union-biotechnology-unspecified-b-cell-lymphomas-likelihood-of-approval/ The leading site for news and procurement in the pharmaceutical industry Mon, 06 Jan 2025 02:05:04 +0000 hourly 1 https://wordpress.org/?v=6.7.1